Prospective, Randomized, Single Masked, Parallel Study Exploring the Effects of a Preservative-Free Ophthalmic Solution Containing Hyaluronic Acid 0.4% and Taurine 0.5% on the Ocular Surface of Glaucoma Patients Under Multiple Long-Term Topical Hypotensive Therapy

被引：0
作者：
Gloria Roberti
Luca Agnifili
Francesca Berardo
Ivano Riva
Michele Figus
Gianluca Manni
Luciano Quaranta
Francesco Oddone
机构：
[1] IRCCS Fondazione G.B. Bietti,Glaucoma Unit
[2] University G. D’Annunzio of Chieti-Pescara,Ophthalmology Clinic, Department of Medicine and Aging Science
[3] University of Pisa,Department of Surgical, Medical, and Molecular Pathology and Critical Care
[4] DSCMT,Section of Ophthalmology
[5] University of Rome Tor Vergata,undefined
[6] Department of Medical and Surgical Specialties,undefined
[7] Radiological Sciences,undefined
[8] and Public Health University of Brescia,undefined
来源：
Advances in Therapy | 2018年 / 35卷
关键词：
Conjunctival goblet cells; Glaucoma; Hyaluronic acid; In vivo confocal microscopy; Ophthalmology; Taurine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：686 / 696
页数：10
相关论文
共 92 条
[1]  
De Moraes CG(2012)Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group Invest Ophthalmol Vis Sci 53 1704-1709
[2]  
Demirel S(2003)Factors for glaucoma progression and the effect of treatment Arch Ophthalmol 121 48-56
[3]  
Gardiner SK(2001)Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery Ophthalmology 108 1943-1953
[4]  
Leske MC(2013)Ocular surface disease and glaucoma: how to evaluate impact on quality of life J Ocul Pharmacol Ther 29 390-394
[5]  
Heijl A(2012)Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication Clin Exp Ophthalmol 40 675-681
[6]  
Hussein M(2012)Ocular surface disease and quality of life in patients with glaucoma Am J Ophthalmol 153 1-9
[7]  
Lichter PR(2002)Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication Br J Ophthalmol 86 418-423
[8]  
Musch DC(2017)TFOS DEWS II iatrogenic report Ocul Surf 15 511-538
[9]  
Gillespie BW(2002)Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye Br J Ophthalmol 86 181-184
[10]  
Rossi GC(2006)Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye Graefes Arch Clin Exp Ophthalnol 244 109-112
12345678910